feed,title,long_url,short_url
Benzinga,SpringWorks In-Licenses TEAD Inhibitor Portfolio For Solid Tumor Settings,https://benzinga.com/general/biotech/21/05/20984379/springworks-in-licenses-tead-inhibitor-portfolio-for-solid-tumor-settings,https://j.mp/2QWucAw
Benzinga,"Himax Stock Shoots Up On Crushing Q1 Earnings, Strong Q2 Guidance",https://benzinga.com/news/earnings/21/05/20985322/himax-stock-shoots-up-on-crushing-q1-earnings-strong-q2-guidance,https://j.mp/3vLcejf
